Asamanya Masik Dharma ki chikitsa

Study on Asrigdar (Dysfunctional Uterine Bleeding) and its management by Bhumyamalki churna and kwath

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/09/028054

Enrollment

Registered

2020-09-25

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified

Interventions

Intervention1: Bhumyamlaki churna and kwath: Bhumyamlaki churna 3-6 gm BD for 3 months Bhumyamlaki kwath 30- 40 ml BD for 3 month Control Intervention1: pushyanug churna: pushyanug churna 3-6 gm BD

Eligibility

Inclusion criteria

Inclusion criteria: 1. Female patients of age from mnarche upto 50 years. 2. Patients willing for trail. 3. patients diagnosed as DUB without organic pathology. 4. patients with either one of them or all having following symptoms like prolonged excessive bleeding or intermenstrual bleeding.

Exclusion criteria

Exclusion criteria: 1.Patients not wiilling for trial. 2.Patients having uterine and pelvic pathology. 3 HB less then 8 gm% . 4 Bleeding due to Coagulation disorders

Design outcomes

Primary

Measure	Time frame
Controlled Vaginal BleedingTimepoint: 3 to 5 months	—

Secondary

Measure	Time frame
Decrease in Associated SymptomsTimepoint: 3 to 5 Months	—

Countries

India

Contacts

Public ContactDr Mamta

Government PG Ayurveda college and Hospital Varanasi

mamtayadav10322@gmail.com7988300946

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026